AAO Gene Therapy Street Team

Article

Karmen Trzupek discusses the complex interpretation of genetic test results

 

In his gene therapy break with the experts , Mark Pennesi compared genetic testing for IRDs to fishing

 

Dominik Fischer presents gene therapy proof-of-concept results in choroideremia

 

Vinit Mahajan explains that RPE65 mutation subtype was unrelated to outcomes in the Luxturna gene therapy trial

 

Christine Kay summarizes her jam packed session on gene therapy

 

Birgit Lorenz looks ahead to ISGEDR 2019 where gene therapy will be a major topic

 

Recent Videos
Arun Upadhyay, PhD, the chief scientific officer and head of research, development, and Medical at Ocugen
Arun Upadhyay, PhD, the chief scientific officer and head of research, development, and Medical at Ocugen
John Brandsema, MD, a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia
John Brandsema, MD, a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia
Barry J. Byrne, MD, PhD, the chief medical advisor of Muscular Dystrophy Association (MDA) and a physician-scientist at the University of Florida
John Brandsema, MD, a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia
Chun-Yu Chen, PhD, a research scientist at Seattle Children’s Research Institute
William Chou, MD, on Targeting Progranulin With Gene Therapy for Frontotemporal Dementia
Alexandra Collin de l’Hortet, PhD, the head of therapeutics at Epic Bio
Related Content
© 2024 MJH Life Sciences

All rights reserved.